Ventas (VTR)
(Delayed Data from NYSE)
$62.11 USD
+0.99 (1.62%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $62.12 +0.01 (0.02%) 4:22 PM ET
3-Hold of 5 3
D Value C Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$62.11 USD
+0.99 (1.62%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $62.12 +0.01 (0.02%) 4:22 PM ET
3-Hold of 5 3
D Value C Growth D Momentum F VGM
Zacks News
Ventas, Inc. is a healthcare real estate investment trust (REIT) that is primarily engaged in acquisition and ownership of senior housing, R&I and healthcare properties, and leasing them to unaffiliated tenants or operating them through independent third-party managers. Ventas offers MOB management, leasing, marketing, facility development and advisory services to well-rated hospitals and health systems throughout the United States through its ownership interest in PMB Real Estate Services LLC and the company’s subsidiary, Lillibridge Healthcare Services, Inc. It also makes secured and non-mortgage loans and other investments relating to senior housing and healthcare properties or operators.
S&P 500 ETFs & Stocks to Buy on a Likely Great Rotation
by Sanghamitra Saha
A low-rate environment, some upbeat earnings and gradual normalcy in the yield curve should move investors from bond to stock ETFs.
Factors to Impact Extra Space Storage (EXR) in Q3 Earnings
by Zacks Equity Research
While Extra Space Storage (EXR) Q3 result will likely mirror gains on high brand value and solid presence in key cities amid healthy self-storage space demand, development boom might fuel competition.
Key Factors to Impact Digital Realty's (DLR) Q3 Earnings
by Zacks Equity Research
While Digital Realty (DLR) Q3 results will likely reflects gains from solid fundamentals of the industry and previous strategic acquisitions, aggressive pricing pressure remains a concern.
UDR to Report Q3 Earnings: What's in Store for the Stock?
by Zacks Equity Research
While UDR Q3 result will likely reflect efforts to boost operating margins on innovative technological solutions and process enhancement, high deliveries of new units might have been a spoilsport.
Why Earnings Season Could Be Great for Ventas (VTR)
by Zacks Equity Research
Ventas (VTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in the Cards for Public Storage's (PSA) Q3 Earnings?
by Zacks Equity Research
Public Storage's (PSA) Q3 performance will likely reflect healthy demand and benefits from its acquisition and expansion efforts, though supply has been rising in a number of the company's markets.
What to Expect From AvalonBay (AVB) This Earnings Season?
by Zacks Equity Research
While AvalonBay (AVB) Q3 results will likely reflect gains from solid rental housing demand, spurred by favorable demographics and household formation, high supply might have curbed its pricing power.
Ventas (VTR) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Ventas' (VTR) Q3 results will likely reflect solid fundamentals of the seniors housing market, which are anticipated to have aided the company's properties and bolstered its top-line growth.
What's in Store for Crown Castle (CCI) This Earnings Season?
by Zacks Equity Research
While high demand for infrastructure and healthy leasing activities might have driven Crown Castle International's (CCI) Q3 performance, pricing power and high-leveraged balance sheet are concerns.
What's in the Cards for SL Green Realty (SLG) in Q3 Earnings?
by Zacks Equity Research
Low leasing velocity and negative net absorption in the Manhattan office market will likely have negatively impacted SL Green Realty's (SLG) Q3 results.
SNH vs. VTR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SNH vs. VTR: Which Stock Is the Better Value Option?
Encouraging Near-Term Outlook for Equity REIT Stocks
by Moumita Chattopadhyay
With market dynamics of individual asset categories playing crucial roles in determining performance and economic indicators looking decent, REIT stocks have scope to excel.
Prudent Investments to Aid Ventas Amid Senior Housing Woes
by Zacks Equity Research
While Ventas' (VTR) investments in strategic markets, and research and innovation projects will likely drive long-term growth, there will be no respite from elevated senior housing asset supply.
Ventas Completes Investment in Quebec Portfolio With LGM
by Zacks Equity Research
Ventas' (VTR) investment in a high-quality senior-housing asset portfolio in Canada will diversify its portfolio, geographic and operator base as well as be accretive to its performance in 2020.
Ventas (VTR) Up 6.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CIO vs. VTR: Which Stock Is the Better Value Option?
by Zacks Equity Research
CIO vs. VTR: Which Stock Is the Better Value Option?
Is it Apt to Hold Welltower (WELL) in Your Portfolio Now?
by Zacks Equity Research
While Welltower (WELL) is aimed at fortifying the senior housing portfolio through strategic investments, near-term earnings dilution from asset sales remains a concern.
4 Reasons Why You Should Add HCP to Your Portfolio Right Now
by Zacks Equity Research
HCP's efforts to expand its medical office and life-science portfolio, a diversified and high-quality portfolio and favorable demographic trends make it an attractive pick.
HCP Surpasses Q2 FFO & Revenue Estimates, Raises Outlook
by Zacks Equity Research
HCP witnesses rise in revenues and net operating income in the second quarter of 2019.
Mid-America Apartment (MAA) Beats Q2 FFO & Revenue Estimates
by Zacks Equity Research
Mid-America Apartment (MAA) witnesses rise in revenues and FFO per share in second-quarter 2019.
Ventas (VTR) Beats Q2 FFO & Revenue Estimates, Raises View
by Zacks Equity Research
Ventas' (VTR) Q2 results display stellar revenues from office and triple net leased portfolio, while its impressive 1H19 performance encourages management to raise the guidance for the ongoing year.
Ventas (VTR) Q2 FFO and Revenues Surpass Estimates
by Zacks Equity Research
Ventas (VTR) delivered FFO and revenue surprises of 1.04% and 1.50%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Ventas (VTR)
by Zacks Equity Research
Ventas (VTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
PS Business Parks (PSB) Q2 FFO Beats on Rental Rate Growth
by Zacks Equity Research
PS Business Parks' (PSB) Q2 performance reflects growth in Same-Park NOI, backed by growth in rental rates, as well as higher NOI from non-Same-Park and multi-family assets.
Can Ventas (VTR) Maintain its Beat Streak in Q2 Earnings?
by Zacks Equity Research
Ventas' (VTR) elevated and upgraded portfolio of medical office buildings (MOBs) likely to witness growth in service revenues during Q2.